Dutch Life Sciences Logo
26 November 2026
Leiden Bio Science Park - CORPUS Congress Centre

Pitch opportunity Startup Forum: Accelerate your Innovation to business!

Hosted by Johnson & Johnson Innovation, supported by Biotech Booster and BOM (Brabantse Ontwikkelings Maatschappij)

Are you building the next breakthrough in Life Sciences? Apply to pitch at the Dutch Life Sciences Startup Forum and showcase your company to leading investors, industry experts, strategic partners, and fellow innovators.

Who Can Apply?
Applications are open to innovative Life Sciences companies based in the Netherlands that are:

  • Active in areas such as biotechnology, therapeutics, diagnostics, medtech, digital health, or enabling technologies.
  • In the proof-of-concept, pre-seed, seed, or early growth stage.
  • Looking for strategic partnerships, customers, collaborators, or investment opportunities.

Selection Process
Applications will be reviewed by the program committee. Shortlisted candidates will be invited to participate in a pitch selection session, taking place in week 44 (28 and 30 October).
Fourteen finalists will be selected: seven companies for the Early-Stage session and seven companies for the Later-Stage session. Confirmation of participation will be provided after the final selection process.
All selected finalists will be invited to the exclusive Speakers & Partners Dinner on the evening preceding the conference.

Participating investors 
The Startup Forum enables you to evaluate new investment opportunities and to meet with the management of the most promising life sciences companies, startups as well as established ventures. After the forum there will be ample opportunity to further discuss future collaborations in one-on-one meetings.

The jury consists of:

  • Lisanne Blauw,  Associate Thuja Capital (chair)
  • Thom Frielink, Investment Manager Curie Capital
  • Viggo van Tendeloo, Director, Early-stage Innovation Benelux J&J Innovative Medicine

General information and registration 
During the conference the forum will be held in two sessions:

  • Part 1 for Early Stage companies (11:15 - 12:30)
  • Part 2 for Later Stage companies (14:00 - 15:15)

Participation in the Investors Forum involves no additional costs. Conference registration is all that is required.

If you are interested to pitch, please fill out the pitch application form.

How to apply

Deadline to apply: 20 October 2026

Application form

Provisional selected pitching companies

Liminal Labs
Simon Van der Jagt
CEO
Liminal Labs Netherlands
InitioCell
Aydın
Oztunali
InitioCell Netherlands
ReFOLD Bio
Else Driehuis
Founder
ReFOLD Bio Netherlands
You2Yourself BV
Johan de Rooij
CSO
You2Yourself BV Netherlands
Mercurna BV
Jenny van Asbeck
CEO
Mercurna BV Netherlands
NeuroTidal Dx
Françoise Dekker
CEO
NeuroTidal Dx Netherlands
Gateway Bio
Mark ter Heide
CEO & Co-founder
Gateway Bio Netherlands
Trained Therapeutix Discovery
Joost Kreijtz
CEO (Europe)
Trained Therapeutix Discovery The Netherlands
ARTIC Technologies
Laure van der Sanden
CEO
ARTIC Technologies Nederland
Vunthera B.V.
Raimond Heukers
CSO
Vunthera B.V. Netherlands
GlycoDiagnostics
Katarina Madunic
CEO
GlycoDiagnostics Netherlands
Ahsan Fazal
Founder & CEO / CTO
Axiomatic B.V. / Inora Netherlands
Alturos Therapeutics BV
Jan Van der Schueren
CEO/CSO
Alturos Therapeutics BV Netherlands
26 November 2026 Leiden Bio Science Park - CORPUS Congress Centre
Book tickets